Siirry sisältöön

Antimicrobial Stewardship Outcomes in University Hospitals

Institutional antimicrobial stewardship programs provide an indispensable multidisciplinary mechanism for curbing resistant pathogen proliferation and optimizing prescribing standards within tertiary healthcare facilities. Structured interventions led by clinical microbiologists and infectious disease pharmacists directly enhance de-escalation compliance, reduce hospital-acquired infection incidence, and lower institutional pharmaceutical expenditure. Systematic synthesis of international hospital outcomes reveals that long-term program sustainability depends upon coordinated governance, rapid diagnostic integration, and continuous audit protocols.

Työn tavoite

To evaluate the clinical, microbiological, and economic outcomes of multidisciplinary antimicrobial stewardship programs across university hospital settings.

Metodologia

Systematic secondary comparative analysis of peer-reviewed tertiary hospital intervention studies, examining consumption indices and resistance patterns.

Tieteellinen uutuusarvo

Integrates clinical, microbiological, and economic outcome metrics into a unified evaluation framework for academic medical centers.

Asiakirjan esikatselu

Tämä on lyhyt esikatselu. Täysversio sisältää laajennetun tekstin kaikille osioille, johtopäätöksen ja muotoillun lähdeluettelon.

PhD Dissertation

Degree:
Antimicrobial Stewardship Outcomes in University Hospitals

Author:

Group

First M. Last

Advisor:

Dr. First Last

City, 2026

Contents

Tiivistelmä
Abstract
Esipuhe
Johdanto
Chapter 1. Conceptual Frameworks and Principles of Hospital Stewardship
1.1 The Evolution of Institutional Antimicrobial Stewardship Programs
1.2 Drivers of Antimicrobial Resistance in Complex Inpatient Settings
1.3 Core Elements and International Policy Guidelines for Academic Centers
1.4 Front-End versus Back-End Intervention Strategies
Chapter 2. Multidisciplinary Governance and Clinical Microbiology Leadership
2.1 Role of Medical Microbiologists and Specialized Pharmacists in Stewardship Rounds
2.2 Integration of Diagnostic Microbiology and Rapid Susceptibility Reporting
2.3 Prescriber Engagement, Behavioral Change, and Institutional Culture
2.4 Educational Modules and Clinical Decision Support Architectures
Chapter 3. Methodological Frameworks for Measuring Programmatic Outcomes
3.1 Quantitative Metrics of Inpatient Antibiotic Consumption
3.2 Standardized Metrics for Clinical and Consumption Assessment
3.4 Comparative Synthesis and Secondary Data Validation Protocols
Chapter 4. Inpatient Clinical and Microbiological Impact Analysis
4.1 Optimization of Empiric Prescribing and Antimicrobial De-escalation
4.2 Incidence Trajectories of Hospital-Acquired Infections and Pathogen Shift
4.3 Intensive Care Unit Outcomes and Infection-Related Mortality Trends
4.4 Pediatric and Adult Inpatient Cohort Discrepancies in Academic Settings
Chapter 5. Economic Performance, Resource Allocation, and Sustainable Implementation
5.1 Cost-Benefit Dynamics of Multidisciplinary Stewardship Intervention
5.2 Pharmacy Formulary Restrictions and Financial Expenditure Reductions
5.3 Resource Constraints and Scalability across Global Tertiary Institutions
5.4 Institutional Policy Maintenance and Long-Term Quality Assurance
Pohdinta
Johtopäätökset
CV
Lähteet
Conclusion

Introduction

Multidisciplinary antimicrobial stewardship initiatives in tertiary-care teaching hospitals represent an essential defense against the global acceleration of antimicrobial resistance [8]. In high-acuity environments such as academic medical centers and intensive care units, excessive and inappropriate antibiotic exposure creates sustained selective pressure, which drives pathogen adaptation and increases the incidence of multidrug-resistant infections [1]. Establishing coordinated stewardship frameworks is therefore vital to optimize antimicrobial administration, protect drug efficacy, and secure favorable clinical outcomes across diverse inpatient populations [8].

Translating structured stewardship guidelines into clinical practice across tertiary-care departments requires coordinated structural mechanisms. Direct involvement of dedicated multidisciplinary teams—specifically consultant medical microbiologists and antimicrobial pharmacists—demonstrates substantial efficacy in curbing inappropriate broad-spectrum utilization through prospective audit, feedback, and targeted bedside rounds [5]. Nevertheless, university hospitals often face operational hurdles, including variable guideline adherence, inconsistent diagnostic turnaround times, and regional disparities in institutional infrastructure, which complicate the sustained achievement of resistance control [1], [5].

Evaluating the broader systemic outcomes of these interventions necessitates rigorous multidimensional appraisal that integrates microbiological, clinical, and economic dimensions [1]. Prior studies indicate that structured stewardship models not only enhance pathogen susceptibility profiles and de-escalation rates but also significantly lower institutional drug expenditures and hospital-acquired infection burdens [1], [8]. By synthesizing evidence from international tertiary care settings, this doctoral dissertation examines the programmatic drivers, evaluation methodologies, and therapeutic consequences that define successful antimicrobial stewardship governance in university hospital ecosystems.

3.2 Standardized Metrics for Clinical and Consumption Assessment

Evaluating the operational effectiveness of hospital stewardship interventions requires a rigorous methodological framework capable of synthesizing multiple distinct outcome dimensions [8]. Standardized assessment relies on established consumption benchmarks, including defined daily doses and days of therapy normalized to inpatient bed utilization [5]. These consumption indicators allow comparative evaluation across diverse hospital wards, tracking shifts from broad-spectrum empiric agents toward targeted narrow-spectrum regimens [1], [5]. In parallel, microbiological metrics such as multiple antibiotic resistance indices and pathogen susceptibility profiles provide essential longitudinal tracking of resistance trends following structured intervention periods [1]. Methodological integrity in secondary evaluation demands systematic cross-referencing between institutional antibiotic policy adherence, diagnostic microbiological turnaround times, and patient safety indicators [1], [8]. By utilizing standardized international criteria to harmonize data from tertiary healthcare centers, the analytical protocol controls for confounding differences in baseline disease severity, institutional formulary access, and clinical unit specializations [5], [8]. This multi-tiered evaluative approach ensures that observed reductions in drug exposure correspond directly to genuine therapeutic optimization, avoidance of hospital-acquired complications, and sustained institutional containment of resistant microbial phenotypes [1], [5].

References

  1. Impact of an antimicrobial stewardship program on antimicrobial resistance patterns, multiple antibiotic resistance indices, clinical outcomes, and cost savings: A pre–post interventional study in the intensive care unit of a tertiary-care hospital in India
    M Bhattacharjee, K Manimekalai, S Bhowmick
    DOI-linkki
  2. Influence of antibiotic consumption on the resistance of Staphylococcus aureus with an antimicrobial stewardship program in a tertiary hospital (2010-2016)
    Di Zhang
    DOI-linkki
  3. IMPACT OF ANTIMICROBIAL STEWARDSHIP PROGRAMS: ANTIBIOTIC CONSUMPTION DURING A 9-YEAR PERIOD IN A TERTIARY CARE CHILDREN’S HOSPITAL IN ITALY
    Carmen D'Amore
    DOI-linkki
  4. Antimicrobial resistance rates do not drive antibiotic consumption in Europe
    Evelina Tacconelli
  5. P34 Impact of medical microbiology lead antimicrobial stewardship rounds on antimicrobial consumption in a level 3 hospital
    Mary Lucey, Sabrina O’Regan, Ruth Waldron
  6. Impact of an antimicrobial stewardship programme on antibiotic usage and resistance in a tertiary hospital in China
    Z.-g. Zhang, F. Chen, Y. Ou
  7. Towards implementing an antibiotic stewardship programme (ASP) in Ecuador: evaluating antibiotic consumption and the impact of an ASP in a tertiary hospital according to World Health Organization (WHO) recommendations
    Hugo Fernando Romo-Castillo, Antonio Pazin-Filho
  8. Antimicrobial Stewardship Programs (AMSPs): Navigating Towards Optimal Antibiotic Use and Combating Antimicrobial Resistance
    Riti Kapoor, Diksha Sood, Kamal Kant Kalia et al.

Lisää työhön lähdeluettelo

Vahvistetut lähteetMuotoilustandarditKorkea omaperäisyysPro-mallit
Launch Offer -25%

Väitöskirja

SFS 5989 (Finnish Citation)

24 €31 €
  • 120–180 sivua.
  • Korkea omaperäisyys
  • Vienti Wordiin
  • Oikea muotoilu
  • Julkinen esikatselu
    Toisen tekijän esikatselua ei voi muuttaa yksityiseksi. Työsi on yksityinen ja täysin ainutlaatuinen.
  • Lähdeluettelo (100+, SFS 5989)
    +1 €
  • Lisää vaihtoehtoisia lähteitä (Uutiset, .gov, .edu)

Väitöskirja

SFS 5989 (Finnish Citation)

Antimicrobial Stewardship Outcomes in University Hospitals | Väitöskirja | Aicademy